Re-oxygenation causes hypoxic tumor regression through restoration of p53 wild-type conformation and post-translational modifications
Authors:
Open Access
- 15 March 2012
- journal article
- research article
- Published by Springer Nature in Cell Death & Disease
- Vol. 3 (3) , e286
Abstract
Hypoxic tumors are resistant to conventional therapies through indirect mechanisms such as the selection of resistant phenotype under chronic hypoxia. Hyperbaric oxygen (HBO) therapy has been shown to increase oxygen level and induce apoptosis in hypoxic tumor. However, it could produce significant adverse effects including oxygen toxic seizures and severe radiation tissue injury due to high pressure. We have shown that repeated oxygenation at 30% O2 (1 atmospheres absolute) results in significant regression of MCF-7 tumor xenografts without any adverse effect. In MCF-7 cells, re-oxygenation showed an eightfold increase in cellular apoptosis. Both in hypoxic tumor and in hypoxic cells, that exclusively favor p53 to exist in mutant conformation, re-oxygenation restores p53 wild-type conformation. The oxygen-mediated rescue of mutant p53 followed by its trans-activation is responsible for the induction of p53-downstream apoptotic, cell-cycle arrest and DNA-repair genes. Further, p53 trans-activation may thus be due to its post-translational modifications as a result of re-oxygenation. We have thus concluded that oxygen therapy without pressure, as opposed to HBO therapy, may be ideal for hypoxic tumor regression, which functions through oxygen-mediated rescue of mutant p53 followed by induction of apoptosis.Keywords
This publication has 23 references indexed in Scilit:
- Reactive Oxygen Species-Mediated p53 Core-Domain Modifications Determine Apoptotic or Necrotic Death in Cancer CellsAntioxidants & Redox Signaling, 2012
- Chaperoning of Mutant p53 Protein by Wild-type p53 Protein Causes Hypoxic Tumor RegressionJournal of Biological Chemistry, 2012
- Reciprocal influence of the p53 and the hypoxic pathwaysCell Death & Disease, 2011
- Posttranslational Modification of p53: Cooperative Integrators of FunctionCold Spring Harbor Perspectives in Biology, 2009
- Hypoxia/reoxygenation: A dynamic regulator of lysyl oxidase‐facilitated breast cancer migrationJournal of Cellular Biochemistry, 2007
- Reoxygenation following hypoxia activates DNA‐damage checkpoint signaling pathways that suppress cell‐cycle progression in cultured human lymphocytesFEBS Letters, 2007
- Cyclic exposure to hypoxia and reoxygenation selects for tumor cells with defects in mitochondrial apoptotic pathwaysThe FASEB Journal, 2004
- Hypoxia attenuates the p53 response to cellular damageOncogene, 2003
- The role of p53 in determining sensitivity to radiotherapyNature Reviews Cancer, 2003
- Partial Oxygen Pressure and Mitochondrial Permeability Transition Affect Germ Cell Apoptosis in the Human TestisThe Journal of Clinical Endocrinology & Metabolism, 1999